Queen Mary University of London

GRP Partnership Intelligence Platform

This page shows where Queen Mary University of London stands. The platform shows where its collaboration could go next.

The peers you choose beside you across both GRP indices, the universities and companies your peers work with that you do not, live funding calls matched to your strengths and a brief ready for your executive. A partner service now onboarding founding partner universities: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access for Queen Mary University of London →

Independence. The index is free, public and independent; no commercial relationship changes any position. The platform, a partner service arranged with each university, reads the published record and cannot move a position.

Featured academics

The researchers behind the standing

Independently verified: current affiliation, public profile and published contact confirmed from the open record.

Professor Paul Coulthard

Professor of Oral and Maxillofacial Surgery, Institute of Dentistry

Coulthard led Queen Mary's Institute of Dentistry into the world top 20 as Dean for Dentistry. An oral and maxillofacial surgeon, he has shaped NHS England commissioning of oral surgery and sedation services, and built teaching and research partnerships with Harvard, Sichuan and Manipal dental schools.

LinkedIn → Featured work →

Professor Sir Mark Caulfield

Vice-Principal (Health) and Professor of Clinical Pharmacology

Knighted for leading the 100,000 Genomes Project as Chief Scientist of Genomics England, Caulfield embedded whole genome sequencing in the NHS. His hypertension genetics discoveries span international consortia, and as CEO of Barts Life Sciences he drives a major research partnership between Queen Mary and Barts Health NHS Trust.

LinkedIn → Featured work →

Professor Chloe Orkin

Professor of Infection and Inequities, Dean for Healthcare Transformation and SHARE Collaborative Director

Orkin played a seminal role in developing the first long-acting injectable HIV treatment and led globally reported research on mpox. Her multi-country trials and equity-driven SHARE Collaborative have changed international treatment guidelines, and she was appointed MBE in 2024 for services to medicine.

LinkedIn → Featured work →

Collaboration profile

Subject standings

This page shows where Queen Mary University of London stands. The platform shows where its collaboration could go next.

The researchers behind the standing

Professor Paul Coulthard

Professor Sir Mark Caulfield

Professor Chloe Orkin

In the news